Prana Selected to Present at Windhover's Therapeutic Area Partnerships Conference by Independent Expert
More News related to PBT
- Permian Basin Royalty Trust Announces November Cash Distribution
- Prana Selected to Present at Windhover's Therapeutic Area Partnerships Conference by Independent Expert
- Permian Basin Royalty Trust Announces October Cash Distribution
- Pemberton plans to acquire majority oil production in the Panny well.
- Permian Basin Royalty Trust (PBT) Approves Lower Monthly Dividend
More News related to PRAN
- Prana Selected to Present at Windhover's Therapeutic Area Partnerships Conference by Independent Expert
- Unusual 11 Mid-Day Movers 8/12: SRLS, RAS, ADCT, WX Higher; CLWR, SYMM, JASO, AVNR Lower
- Prana Biotech (PRAN) Rallying on PBT2 Patent News
- Morning Movers 8/5: ONT, CMLS, INO, RDN, SCLN, PRAN, NVAX Higher; XRM, CVGI, VCLK, ACAS, SXE, AMRI, GCA Lower
- Prana Biotech (PRAN) Secures Key Patent Protecting PBT2
More News related to Press Releases
- Propalms, Inc. Launches New Blog and Twitter Sites to Expand Its Global Reach
- Lombardi Customer, Homeloan Management Ltd., Wins Global Excellence Award for BPM Project
- A.M. Best Removes From Under Review, Affirms Ratings of Liberty Bankers Life Insurance Company and Subsidiary; Outlook Negative
- TisBest Philanthropy Teams With Jumping Cracker Beans to Introduce New Greeting Cards That Benefit Charities
- Beaufield Surveys for SEDEX in Labrador Trough, Stakes More Claims
NEW YORK, Nov. 11, 2009 (GLOBE NEWSWIRE) -- Prana Biotechnology (Nasdaq: PRAN) (ASX: PBT) today announced that Dr. Rudy Tanzi, Scientific Advisory Board will present at the 2009 Windhover's Therapeutic Area Partnerships Conference being held November 18 at 3:30PM at the Westin Copley Place Hotel in Boston.
Prana's lead Alzheimer's disease compound, PBT2, has been chosen by Windhover Information and independent expert Harry Tracy, as one of the top 10 most interesting neuroscience projects in development available for strategic partnering.
About Windhover
Windhover Information Inc. (www.windhover.com), an Elsevier company, has led the field in providing analysis of the healthcare industry to decision-makers at all levels since the founding of its flagship publication, IN VIVO, the Business & Medicine Report, in 1983. Windhover provides its information and analysis in many formats, including print, electronic databases, international conferences and webinars.
About Prana Biotechnology Limited
Prana Biotechnology was established to commercialize research into Alzheimer's Disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the Australian Stock Exchange in March 2000 and listed on NASDAQ in September 2002. Researchers at prominent international institutions including The University of Melbourne, The Mental Health Research Institute (Melbourne) and Massachusetts General Hospital, a teaching hospital of Harvard Medical School, contributed to the discovery of Prana's technology.
For further information please visit the Company's web site at www.pranabio.com.
CONTACT: Grayling Global
Investor Relations
Leslie Wolf-Creutzfeldt
646-284-9472
leslie.wolf-creutzfeldt@us.grayling.com
Media Relations
Stacy Dimakakos
646-284-9417
stacy.dimakakos@us.grayling.com
Related Categories
Press ReleasesStocks Mentioned
+0.24
-0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
